Results 131 to 140 of about 411,617 (199)

No evidence of increased hypoglycaemia attributed to physical activity with once-weekly insulin icodec versus once-daily basal insulin degludec in type 1 diabetes: A post hoc analysis of ONWARDS 6. [PDF]

Diabetes Obes Metab
Sourij H, Bracken RM, Carstensen L, Pagliaro Rocha TM, Kehlet Watt S, Philis-Tsimikas A.   +5 more
europepmc   +1 more source

Evaluation of Pharmacokinetics and Safety of the Biosimilar (B01711) and Insulin Degludec/Insulin Aspart (IDegAsp, Ryzodeg) in Healthy Chinese Adults in a Randomized, Open-Label, Single-Dose, Crossover, Phase I Study. [PDF]

Drug Des Devel Ther
Liu H, Cao H, Li T, Chen X, Yu H, Sun J, Yu Y.   +6 more
europepmc   +1 more source

Insulin Degludec in People with Type 2 Diabetes in China: A Non-interventional, Retrospective Chart Review Study (CN-TREAT). [PDF]

Diabetes Ther
Wang W, Chang X, Lehrskov LL, Li L, Nordentoft M, Quan J, Sha Y, Zhong X, Yang C, Zhu D.   +9 more
europepmc   +1 more source

Correction to "Effects of Insulin Glargine U300 Versus Insulin Degludec U100 on Glycemic Variability, Hypoglycemia, and Diet Evaluated by Continuous Glucose Monitoring in Type 1 Diabetes: A Retrospective Cross-Sectional Study". [PDF]

Kaohsiung J Med Sci
europepmc   +1 more source

Effects of insulin glargine U300 versus insulin degludec U100 on glycemic variability, hypoglycemia, and diet evaluated by continuous glucose monitoring in type 1 diabetes: a retrospective cross-sectional study. [PDF]

Kaohsiung J Med Sci
Tsai PL, Lin CH, Huang YY, Chen HY, Lin YH.   +4 more
europepmc   +1 more source

Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults With Type 2 Diabetes in the Philippines: Results from a Prospective, Non-interventional, Real-World Study. [PDF]

J ASEAN Fed Endocr Soc
Nicodemus N, Ang-Golangco N, Aquitania G, Ardeña GJR, Dampil OA, Fernando RE, Flor NT, Kho S, Mirasol R, Panelo A, Pasaporte F, Puno-Rocamora M, Shoeb A, Tolentino M.   +13 more
europepmc   +1 more source

Initiation or switch to insulin degludec/insulin aspart in adults with type 2 diabetes in India: Results from a prospective, non-interventional, real-world study. [PDF]

J Family Med Prim Care
Baruah MP, Aneja P, Pitale S, Bhograj A, Agrawala RK, Aggarwal A, Mahadev PG, Madhavdas DC, Shah S, John M, Pathan MKA, Revanna M, Chandrappa M, Singh KP.   +13 more
europepmc   +1 more source

Comparison of efficacy and safety of insulin degludec/liraglutide and insulin glargine U-100/lixisenatide in individuals with type 2 diabetes mellitus using professional continuous glucose monitoring. [PDF]

J Diabetes Investig
Kawaguchi Y, Hajika Y, Rinka M, Masumoto K, Sawa J, Hamazaki K, Kumeda Y.   +6 more
europepmc   +1 more source

Efficacy and Safety of Insulin Degludec/Insulin Aspart versus Biphasic Insulin Aspart 30 in Patients with Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials. [PDF]

Iran J Public Health
Niu YL, Zhang Y, Song ZY, Zhao CZ, Luo Y, Wang Y, Yuan J.   +6 more
europepmc   +1 more source